Whats in it for you
Ideal timing for testing: Before starting your GLP-1 medication (baseline) 4-6 weeks after starting treatment After any dose increase Quarterly during stable dosing Immediately if warning symptoms appear People at higher risk for electrolyte problems include those over 65, anyone with kidney disease, heart failure patients, people taking diuretics, and anyone with persistent GI symptoms lasting beyond the first 8-12 weeks of treatment
They will not close a hanging fold of skin, and waiting longer than a year rarely changes the verdict
Description Overview 5-Amino-1MQ is a selective NNMT inhibitor that elevates cellular NAD+ and SAM to enhance mitochondrial function, fat oxidation, insulin sensitivity, and overall metabolic efficiency, with preclinical data indicating preferential visceral fat loss and a favorable safety profile
For those interested in additional body sculpting options, procedures like awake liposuction, abdominoplasty, or Botox treatments can further refine your results
Gradual dose adjustments improve tolerance, allowing steady, sustainable progress without extreme dieting or rapid fluctuations
